Can you say "suitable for all" in Indian pharma promotional material?
Conditionally restricted. The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 governs promotional material for doctors. It does not name the phrase 'suitable for all'. But in that material, absolute claims of universal suitability are restricted by its general requirements. Promotion must be consistent with the terms of the marketing approval (Clause 1.2). Information must not mislead and must be capable of substantiation (Clause 1.3).
In short
- Status: conditionally restricted.
- Governing instrument: Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, Clauses 1.2 and 1.3. Clause 2.2 also applies where the material uses the word 'safe' without qualification or states categorically that the drug has no side effects.
- UCPMP 2024 does not name this term.
- First checked by two independent AI models against the live web. Citations re-checked on 6 October 2026. They were checked against the official text of the Code.
Which instrument governs this
Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, Clauses 1.2 and 1.3. Clause 2.2 also applies where the material uses the word 'safe' without qualification or states categorically that the drug has no side effects.
UCPMP 2024 does not name this phrase. The main test is whether the claim matches the approved indication and population (Clause 1.2). Evidence alone cannot fix a claim that goes beyond the marketing approval.
What verification returned
The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 governs promotional material for doctors. It does not name the phrase 'suitable for all'. But in that material, absolute claims of universal suitability are restricted by its general requirements. Promotion must be consistent with the terms of the marketing approval (Clause 1.2). Information must not mislead and must be capable of substantiation (Clause 1.3). Where the phrase implies the drug is safe for everyone, it can mislead by implication, which Clause 1.3 forbids. If the material uses the word 'safe' without qualification, or says categorically that there are no side effects, Clause 2.2 also applies. A claim that goes beyond the approved indication and population cannot be fixed with evidence.
How this was checked
Two independent AI models were asked the same question against the live web. They were Gemini 2.5 Pro with Google Search grounding, and OpenAI GPT-5 with web search. A third model then judged whether they agreed on the substance rather than the wording. Every source cited was fetched over HTTP to confirm it exists. A fetch confirms only that a source exists. It does not confirm that the source supports the statement. So on 6 October 2026 the citations on this page were re-checked. They were checked against the official text of the Code. They were corrected where they were wrong. Terms that did not reach agreement between the models are not published.
Sources checked
Frequently asked questions
Can you say "suitable for all" in pharma promotion in India?
Conditionally restricted. The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 governs promotional material for doctors. It does not name the phrase 'suitable for all'. But in that material, absolute claims of universal suitability are restricted by its general requirements. Promotion must be consistent with the terms of the marketing approval (Clause 1.2). Information must not mislead and must be capable of substantiation (Clause 1.3).
Which code governs the use of 'suitable for all'?
Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, Clauses 1.2 and 1.3. Clause 2.2 also applies where the material uses the word 'safe' without qualification or states categorically that the drug has no side effects.
How reliable is this answer?
It was first checked on 10 September 2026 by two independent AI models, Gemini 2.5 Pro and GPT-5. Both worked against the live web, and their answers were adjudicated for agreement. Every cited source was fetched to confirm it exists. A fetch confirms only that a source exists. So on 6 October 2026 the citations were re-checked. They were checked against the official text of the Code. They were corrected where they were wrong. Terms that did not reach agreement are not published. The Code can change, so check against the source before relying on it.
Check it before MLR does
Collateral Advisor flags this term in the pages you upload, for your team to review in context.
Free trial, no card needed. MarketingSense is a pre-MLR advisory assistant. Your medical, legal and regulatory team still makes the final call.